Nicolo Piazza

Nicolo Piazza

Auto-generated profile, based on publicly available information

Nicolo Piazza

Department of Medicine, Division of Cardiology, McGill University Health Center , Montreal, Quebec

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in European Heart Journal
Verified
Journal Article
Closed access
VCVARC-3 WRITING COMMITTEE
VARC-3 WRITING COMMITTEE
PGPhilippe Généreux
Philippe Généreux
NPNicolo Piazza
Nicolo Piazza
MAMaria C Alu
Maria C Alu
TNTamim Nazif
Tamim Nazif
MLMartin B Leon
Martin B Leon
Aims : The Valve Academic Research Consortium (VARC), founded in 2010, was intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these endpoints for transcatheter and surgical aortic valve clinical trials. Rapid evolution of the field, including the emergence of new complications, expanding clinical indications, and novel therapy strategies have mandated further refinement and expansion of these definitions to ensure clinical relevance. This document provides an update of the most appropriate clinical endpoint definitions to be used in the conduct of transcatheter and surgical aortic valve clinical research.Methods and results : Several years after the publication of the VARC-2 manuscript, an in-person meeting was held involving over 50 independent clinical experts representing several professional societies, academic research organizations, the US Food and Drug Administration (FDA), and industry representatives to (i) evaluate utilization of VARC endpoint definitions in clinical research, (ii) discuss the scope of this focused update, and (iii) review and revise specific clinical endpoint definitions. A writing committee of independent experts was convened and subsequently met to further address outstanding issues. There were ongoing discussions with FDA and many experts to develop a new classification schema for bioprosthetic valve dysfunction and failure. Overall, this multi-disciplinary process has resulted in important recommendations for data reporting, clinical research methods, and updated endpoint definitions. New definitions or modifications of existing definitions are being proposed for repeat hospitalizations, access site-related complications, bleeding events, conduction disturbances, cardiac structural complications, and bioprosthetic valve dysfunction and failure (including valve leaflet thickening and thrombosis). A more granular 5-class grading scheme for paravalvular regurgitation (PVR) is being proposed to help refine the assessment of PVR. Finally, more specific recommendations on quality-of-life assessments have been included, which have been targeted to specific clinical study designs.Conclusions : Acknowledging the dynamic and evolving nature of less-invasive aortic valve therapies, further refinements of clinical research processes are required. The adoption of these updated and newly proposed VARC-3 endpoints and definitions will ensure homogenous event reporting, accurate adjudication, and appropriate comparisons of clinical research studies involving devices and new therapeutic strategies.

1 December 2014 in JACC
Verified
Journal Article
Closed access
DMDarren Mylotte
Darren Mylotte
TLThierry Lefevre
Thierry Lefevre
LSLars Søndergaard
Lars Søndergaard
YWYusuke Watanabe
Yusuke Watanabe
TMThomas Modine
Thomas Modine
NPNicolo Piazza
Nicolo Piazza

28 September 2014 in European Heart Journal
Verified
Journal Article
Open access
PDF file
DMDarren Mylotte
Darren Mylotte
AAAli Andalib
Ali Andalib
PTPascal Thériault-Lauzier
Pascal Thériault-Lauzier
MDMagdalena Dorfmeister
Magdalena Dorfmeister
MGMina Girgis
Mina Girgis
NPNicolo Piazza
Nicolo Piazza
A comprehensive description of transcatheter heart valve (THV) failure has not been performed. We undertook a systematic review to investigate the aetiology, diagnosis, management, and outcomes of THV failure. The systematic review was performed in accordance with the PRISMA guidelines using EMBASE, MEDLINE, and Scopus. Between December 2002 and March 2014, 70 publications reported 87 individual cases of transcatheter aortic valve implantation (TAVI) failure. Similar to surgical bioprosthetic heart valve failure, we observed cases of prosthetic valve endocarditis (PVE) (n = 34), structural valve failure (n = 13), and THV thrombosis (n = 15). The microbiological profile of THV PVE was similar to surgical PVE, though one-quarter had satellite mitral valve endocarditis, and surgical intervention was required in 40% (75% survival). Structural valve failure occurred most frequently due to leaflet calcification and was predominantly treated by redo-THV (60%). Transcatheter heart valve thrombosis occurred at a mean 9 ± 7 months post-implantation and was successfully treated by prolonged anticoagulation in three-quarters of cases. Two novel causes of THV failure were identified: late THV embolization (n = 18); and THV compression (n = 7) following cardiopulmonary resuscitation (CPR). These failure modes have not been reported in the surgical literature. Potential risk factors for late THV embolization include low prosthesis implantation, THV undersizing/underexpansion, bicuspid, and non-calcified anatomy. Transcatheter heart valve embolization mandated surgery in 80% of patients. Transcatheter heart valve compression was noted at post-mortem in most cases. Transcatheter heart valves are susceptible to failure modes typical to those of surgical bioprostheses and unique to their specific design. Transcatheter heart valve compression and late embolization represent complications previously unreported in the surgical literature.

1 July 2011 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
NPNicolo Piazza
Nicolo Piazza
SBSabine Bleiziffer
Sabine Bleiziffer
GBGernot Brockmann
Gernot Brockmann
RHRuge Hendrick
Ruge Hendrick
MDMarcus-André Deutsch
Marcus-André Deutsch
RLRüdiger Lange
Rüdiger Lange

1 July 2011 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
NPNicolo Piazza
Nicolo Piazza
SBSabine Bleiziffer
Sabine Bleiziffer
GBGernot Brockmann
Gernot Brockmann
RHRuge Hendrick
Ruge Hendrick
MDMarcus-André Deutsch
Marcus-André Deutsch
RLRüdiger Lange
Rüdiger Lange

1 January 2021 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
JBJeremy Ben-Shoshan
Jeremy Ben-Shoshan
HAHind Alosaimi
Hind Alosaimi
PLPascal Thériault Lauzier
Pascal Thériault Lauzier
MPMichele Pighi
Michele Pighi
YTYeela Talmor-Barkan
Yeela Talmor-Barkan
NPNicolo Piazza
Nicolo Piazza